These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 32611256)

  • 1. Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection.
    de Castro CG; Gregianin LJ; Burger JA
    Leuk Lymphoma; 2020 Oct; 61(10):2536-2537. PubMed ID: 32611256
    [No Abstract]   [Full Text] [Related]  

  • 2. Mass Drug Administration and Worms Experience in Africa: Envisage Repurposing Ivermectin for SARS-COV-2.
    Wamae CN
    Am J Trop Med Hyg; 2020 Jul; 103(1):10-11. PubMed ID: 32458795
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug Repurposing Study Pinpoints Potential COVID-19 Antivirals.
    Abbasi J
    JAMA; 2020 Sep; 324(10):928. PubMed ID: 32897326
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug repurposing in the era of COVID-19: a call for leadership and government investment.
    Martin JH; Bowden NA
    Med J Aust; 2020 Jun; 212(10):450-452.e1. PubMed ID: 32372435
    [No Abstract]   [Full Text] [Related]  

  • 5. "What Were You Before the War?" Repurposing Psychiatry During the COVID-19 Pandemic.
    Nicol GE; Karp JF; Reiersen AM; Zorumski CF; Lenze EJ
    J Clin Psychiatry; 2020 Apr; 81(3):. PubMed ID: 32271506
    [No Abstract]   [Full Text] [Related]  

  • 6. Atypical Imaging Findings in Leukemia With SARS-CoV-2 Infection.
    Zhou S; Wu G
    AJR Am J Roentgenol; 2020 Aug; 215(2):W31-W32. PubMed ID: 32352310
    [No Abstract]   [Full Text] [Related]  

  • 7. Repurposing old drugs as antiviral agents for coronaviruses.
    Yang CW; Peng TT; Hsu HY; Lee YZ; Wu SH; Lin WH; Ke YY; Hsu TA; Yeh TK; Huang WZ; Lin JH; Sytwu HK; Chen CT; Lee SJ
    Biomed J; 2020 Aug; 43(4):368-374. PubMed ID: 32563698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Silico Drug Repurposing for SARS-CoV-2 Main Proteinase and Spike Proteins.
    Maffucci I; Contini A
    J Proteome Res; 2020 Nov; 19(11):4637-4648. PubMed ID: 32893632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tenecteplase (and common sense) in short supply during the COVID-19 pandemic.
    Parsons M; Churilov L; Schutte AE; Levi C
    Med J Aust; 2020 Nov; 213(10):442-443.e1. PubMed ID: 33099288
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chronic granulocytic leukemia with COVID-19 pneumonia: a case report].
    Sheng LS; Li DJ; Zhou JF; Huang W
    Zhonghua Xue Ye Xue Za Zhi; 2020 Jul; 41(7):601-602. PubMed ID: 32394688
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular Binding Mechanism and Pharmacology Comparative Analysis of Noscapine for Repurposing against SARS-CoV-2 Protease.
    Kumar N; Sood D; van der Spek PJ; Sharma HS; Chandra R
    J Proteome Res; 2020 Nov; 19(11):4678-4689. PubMed ID: 32786685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ivermectin Docks to the SARS-CoV-2 Spike Receptor-binding Domain Attached to ACE2.
    Lehrer S; Rheinstein PH
    In Vivo; 2020; 34(5):3023-3026. PubMed ID: 32871846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the impact of lockdown: Fresh challenges for the care of haematology patients in the COVID-19 pandemic.
    Willan J; King AJ; Djebbari F; Turner GDH; Royston DJ; Pavord S; Collins GP; Peniket A
    Br J Haematol; 2020 Jun; 189(6):e224-e227. PubMed ID: 32369622
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19 and childhood acute lymphoblastic leukemia.
    Greaves M
    Pediatr Blood Cancer; 2020 Dec; 67(12):e28481. PubMed ID: 32860652
    [No Abstract]   [Full Text] [Related]  

  • 15. Artificial intelligence approach fighting COVID-19 with repurposing drugs.
    Ke YY; Peng TT; Yeh TK; Huang WZ; Chang SE; Wu SH; Hung HC; Hsu TA; Lee SJ; Song JS; Lin WH; Chiang TJ; Lin JH; Sytwu HK; Chen CT
    Biomed J; 2020 Aug; 43(4):355-362. PubMed ID: 32426387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing minocycline for COVID-19 management: mechanisms, opportunities, and challenges.
    Singh H; Kakkar AK; Chauhan P
    Expert Rev Anti Infect Ther; 2020 Oct; 18(10):997-1003. PubMed ID: 32552044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-β-1a Inhibition of Severe Acute Respiratory Syndrome-Coronavirus 2 In Vitro When Administered After Virus Infection.
    Clementi N; Ferrarese R; Criscuolo E; Diotti RA; Castelli M; Scagnolari C; Burioni R; Antonelli G; Clementi M; Mancini N
    J Infect Dis; 2020 Aug; 222(5):722-725. PubMed ID: 32559285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CL
    Chitranshi N; Gupta VK; Rajput R; Godinez A; Pushpitha K; Shen T; Mirzaei M; You Y; Basavarajappa D; Gupta V; Graham SL
    J Transl Med; 2020 Jul; 18(1):278. PubMed ID: 32646487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review.
    Santos J; Brierley S; Gandhi MJ; Cohen MA; Moschella PC; Declan ABL
    Viruses; 2020 Jun; 12(7):. PubMed ID: 32629804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal?
    Jans DA; Wagstaff KM
    Cells; 2020 Sep; 9(9):. PubMed ID: 32942671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.